Nitroprusside for Prevention of no-Reflow in Primary Angioplasty
NCT00128791
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Myocardial Infarction
Interventions
DRUG:
Nitroprusside
Sponsor
Soroka University Medical Center